Pfizer’s Omicron-Targeting Covid-19 Vaccines Generate Stronger Immune Response
Pfizer Inc and BioNTech SE vaccines modified to target the Omicron variant produced a significantly higher immune response than the companies’ currently available vaccine in one study, they said. A modified booster injection targeting Omicron specifically increased neutralizing antibody levels 13.5 to 19.6 times higher than the current injection in study volunteers one month after …
Pfizer’s Omicron-Targeting Covid-19 Vaccines Generate Stronger Immune Response Read More »